title: Enhancing organ pool by statins: is this the future?
authors: Jorge
authors: J
authors: Gracia-Sancho
mesh_terms: D000818:Animals; D000069059:Atorvastatin; D005234:Fatty Liver / Q000188:drug therapy*; D006538:Heptanoic Acids / Q000494:pharmacology*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects*; D008297:Male; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*; D065626:Non-alcoholic Fatty Liver Disease; D009765:Obesity / Q000188:drug therapy*; D011758:Pyrroles / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000517:prevention & control*; D051197:Toll-Like Receptor 4 / Q000187:drug effects*
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; C493487:Tlr4 protein, mouse; D051197:Toll-Like Receptor 4; D000069059:Atorvastatin; D052250:Nitric Oxide Synthase Type III; C496315:Nos3 protein, mouse